Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke. "3C"


Phase 3 Results N/A

Eligibility Criteria

Inclusion Criteria

- patients from 3 to 6 months after ischemic stroke
- hemispheric infarction
- paresis from 2 to 4 scores by Medical Research Council Weakness Scale (MRC)

Exclusion Criteria

- history of seizures
- pregnancy, lactation
- cognitive deficiency (poor compliance)
- acute renal failure
- acute hepatic failure
- oncological history
- cardiac pacemakers and other metal implants
- regular intake of any nootropic drugs
- Modified Ashford Scale scores 3 and more
- regular intake of anticonvulsants, neuromuscular relaxants